Amring Pharmaceuticals
  • Generics
  • Partner
  • Company
  • News
  • Contact
Select Page

amring-timeline-2015-horizontal

Recent Posts

  • Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V.
  • Amring Pharmaceuticals Inc. Acquires LYSTEDA®
  • Ferring US Issues Voluntary Nationwide Recall of Desmopressin Acetate Nasal Spray 10 mcg/0.1mL
  • Amring Pharmaceuticals Announces the Launch of Two Valued Pharmaceutical Generics
  • Amring Pharmaceuticals Announces 2018/19 Launches

Recent Comments

    Archives

    • March 2021
    • December 2020
    • August 2020
    • June 2019
    • January 2019
    • July 2018
    • June 2017
    • March 2017
    • April 2016
    • March 2016
    • January 2016
    • December 2015
    • June 2015

    Categories

    • News
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Amring

    Get in touch

    844.304.4828 info@amringpharma.com More contact options

    Get to know Amring

    Products Partner Company LinkedIn

    What’s new

    Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it has launched two valued drugs into its generic portfolio and to the U.S. Market...

    More news & events